Position in ACRV
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$472,128
+$143,545 QoQ
Shares Held
265,241
+12.2% QoQ
Ownership
0.619%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#10
of 46 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ACRV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,569,550 across 521 Biotechnology names. ACRV ranks #360 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in ACRV
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $472,128 | 265,241 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $328,583 | 236,391 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $477,716 | 198,223 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $347,578 | 192,033 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $195,590 | 164,362 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $621,405 | 306,111 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,814,361 | 301,389 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $2,114,721 | 302,103 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,788,678 | 308,393 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $1,736,348 | 242,846 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $930,864 | 189,200 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $1,812,184 | 189,559 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $2,312,750 | 178,453 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $2,225,876 | 175,404 | Shares | Defined | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||